Colleen Kusy

Q: What is Colleen Kusy's success rate?

Colleen Kusy currently has a success rate of 75.04119466371769.

Q: What is the average return of Colleen Kusy's calls?

Their stock ratings have generated an average return of 42.794169213503544.

Baird | Healthcare

Colleen Kusy is an analyst from Baird specializing in the Healthcare sector. Ranked #909 out of 4773 analysts, they have issued 12 stock ratings with a success rate of 75.04% and an average return of 42.79%.

With 12 ratings to date, Colleen Kusy is beginning to establish credibility in the Healthcare sector. They have achieved a success rate of 75.04% and an average return of 42.79%, highlighting promising potential as their track record develops further.

#909

Out of 4773

Total Ratings

+75.04%

Success Rate

+42.79%

Average Return

Recent Ratings Analysis

CLYM

Buy

Sep 03, 2026

Target

$25.00

Current

$14.25

Performance

-2.33%

Colleen Kusy rated CLYM as Outperform on Sep 03, 2026, setting a price target of 25. Shares have remained stable near 14.25, leaving the 25 target still in play.

ARGX

Hold

Jul 27, 2026

Target

$932.00

Current

$984.39

Performance

10.75%

On Jul 27, 2026, ARGX was given a Neutral rating by Colleen Kusy, with a target price of 932. The stock rallied from 984.39 to 984.39 after the Hold rating, surprising to the upside.

OCUL

Buy

Jun 18, 2026

Target

$30.00

Current

$10.49

Performance

11.24%

OCUL received a Outperform rating from Colleen Kusy on Jun 18, 2026, aiming for 30. Momentum has favored the Buy call, with shares climbing from 10.49 to 10.49, rewarding those who trusted the recommendation.

OCS

Buy

Jun 02, 2026

Target

$38.00

Current

$10.56

Performance

—

On Jun 02, 2026, Colleen Kusy published a Outperform outlook on OCS, with a target of 38. So far, the stock has neither confirmed nor rejected the Buy case, holding within range of 10.56.

SYRE

Buy

Apr 14, 2026

Target

$90.00

Current

$90.60

Performance

41.54%

Colleen Kusy on Apr 14, 2026 assigned SYRE a Outperform rating, with a price target of 90. The Buy call aligned well with market performance, producing a gain of 41.54%.

NUVL

Buy

Nov 18, 2025

Target

$158.00

Current

$123.96

Performance

18.92%

On Nov 18, 2025, Colleen Kusy reaffirmed NUVL with a Outperform rating, targeting 158. The recommendation was supported by strong follow-through as the stock rose from 123.96 to 123.96.

COGT

Hold

Nov 11, 2025

Target

$34.00

Current

$33.41

Performance

-0.03%

COGT was rated Neutral by Colleen Kusy on Nov 11, 2025, with a price objective of 34. Flat performance suggests the Hold view was reasonable.

APLS

Buy

Oct 31, 2025

Target

$52.00

Current

$41.03

Performance

91.10%

On Oct 31, 2025, Colleen Kusy initiated coverage on APLS with a Outperform rating and target of 52. The stock’s climb of 91.10% since the call highlights the foresight in the rating.

ELVN

Buy

Jun 16, 2025

Target

$52.00

Current

$54.32

Performance

135.25%

Colleen Kusy issued a Outperform recommendation for ELVN on Jun 16, 2025, price target set at 52. Investors following the Buy call captured upside momentum, with shares now at 54.32.

AGEN

Hold

Mar 12, 2025

Target

$3.00

Current

$6.94

Performance

271.12%

On Mar 12, 2025, AGEN was evaluated by Colleen Kusy, who gave a Neutral rating and target of 3. Investors who stayed in despite the Hold saw upside of 271.12%.

CHRS

Buy

Dec 05, 2024

Target

$6.00

Current

$1.33

Performance

-11.92%

Colleen Kusy rated CHRS as Outperform on Dec 05, 2024, setting a price target of 6. The stock has underperformed, dropping 11.92% despite the bullish target of 6.

MRSN

Hold

Aug 14, 2024

Target

$3.00

Current

$29.08

Performance

2264.23%

On Aug 14, 2024, MRSN was given a Neutral rating by Colleen Kusy, with a target price of 3. The stock rallied from 29.08 to 29.08 after the Hold rating, surprising to the upside.

Frequency Asked Questions

Who is Colleen Kusy?

Colleen Kusy is an analyst from Baird specializing in the Healthcare sector.

What is Colleen Kusy's success rate?

Colleen Kusy currently has a success rate of +75.04%.

How many ratings has Colleen Kusy issued?

Colleen Kusy has issued 12 stock ratings so far.

What is the average return of Colleen Kusy's calls?

Their stock ratings have generated an average return of +42.79%.

What is Colleen Kusy's ranking?

Colleen Kusy is ranked #909 out of 4773 analysts.

What types of ratings does Colleen Kusy give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Colleen Kusy?

You can follow Colleen Kusy by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Colleen Kusy?

Their latest rating was a Buy on CLYM issued on 2026-09-03.